Age-based discrimination in medicine is not a fringe concern — it is a documented, widespread problem affecting millions of older adults across the globe. When patients are denied screenings, surgeries, or clinical trial participation simply because of their age, the consequences extend far beyond any individual case. They reveal systemic bias embedded in healthcare protocols, institutional policies, and the unexamined assumptions that quietly guide clinical judgment every day.
The International Association of Gerontology and Geriatrics (IAGG) has positioned itself at the forefront of identifying, researching, and actively challenging these inequities. As a global body representing gerontological and geriatric societies across multiple world regions, IAGG brings together researchers, clinicians, and policymakers committed to advancing age-equitable healthcare standards. Through advocacy, scientific inquiry, and sustained international collaboration, the organization addresses one of the most underacknowledged injustices in modern medicine: the systematic undervaluing of older patients’ health needs.
Defining Age-Based Discrimination: The IAGG Perspective
Ageism in healthcare — commonly referred to as medical ageism — occurs when clinical decisions are shaped by a patient’s age rather than their individual medical condition, functional status, or personal preferences. This distinction is critically important. Not every age-related clinical consideration constitutes discrimination; some treatments genuinely carry different risk profiles for older versus younger patients. The problem arises when chronological age replaces actual clinical assessment as the primary basis for care decisions.
International Association of Gerontology and Geriatrics researchers describe medical ageism as operating on two distinct levels: attitudinal and structural. Attitudinal ageism surfaces through clinician beliefs — often unconscious — that older patients are less deserving of aggressive treatment, less capable of benefiting from interventions, or less likely to adhere to complex care plans. Structural ageism, by contrast, is embedded in institutional systems: arbitrary age caps on clinical trial enrollment, age-based resource allocation protocols during medical crises, and coverage limitations tied to age thresholds.
The distinction IAGG draws between appropriate, age-informed clinical care and discriminatory, age-based exclusion is central to the organization’s entire framework. Adjusting a medication dosage for an 80-year-old based on established pharmacokinetic evidence is sound clinical practice. Withholding a cancer treatment from that same patient solely because of their age — without evaluating functional fitness, prognosis, or personal treatment goals — crosses a clear ethical and clinical line.
How Age-Based Discrimination Manifests in Medical Settings
Understanding where medical ageism occurs is a prerequisite for dismantling it. IAGG research and affiliated studies have documented the clinical environments and decision points where older adults are most likely to encounter age-based barriers to care. The following areas reflect consistent patterns that the International Association of Gerontology and Geriatrics has specifically addressed in its advocacy and scientific work.
- Cardiovascular care: Older patients — particularly women over 75 — are referred less frequently for cardiac catheterization, bypass surgery, and implantable cardiac devices, even when standard clinical criteria are fully met.
- Oncology treatment: Age is routinely cited as justification for recommending less intensive cancer therapies or excluding patients from clinical trials entirely, regardless of an individual’s functional capacity or life expectancy.
- Mental health services: Depression, anxiety, and cognitive changes in older adults are frequently under-diagnosed. Symptoms are attributed to “normal aging” rather than recognized and treated as discrete, manageable conditions.
- Emergency and critical care: Triage frameworks — particularly those activated during resource-scarce scenarios such as the COVID-19 pandemic — have in some cases incorporated age as a factor in allocating critical resources, including mechanical ventilation.
- Pain management: Research linked to IAGG-affiliated work consistently demonstrates that older patients receive fewer pain management interventions than younger counterparts presenting with clinically comparable conditions.
- Preventive medicine: Older adults remain significantly underrepresented in cancer screening programs, vaccination initiatives, and lifestyle intervention studies, limiting their access to care that could prevent or delay serious illness.
Each of these scenarios reflects a pattern in which age functions as a filter that overrides clinical evidence. Taken together, they illustrate the breadth of the challenge that the International Association of Gerontology and Geriatrics has made central to its global mission.
The Research Foundation: Evidence Behind Age-Based Disparities
IAGG’s position on age-based discrimination is anchored in rigorous scientific evidence, not advocacy alone. Studies in gerontology and geriatric medicine have consistently demonstrated that chronological age is a poor predictor of treatment benefit or risk when compared to more meaningful clinical variables: functional status, comorbidity burden, cognitive capacity, and patient preferences.
Among the most consequential findings highlighted in IAGG contexts is the systematic underrepresentation of older adults in clinical trials. When regulatory agencies approve treatments based on trials that excluded patients over 65 or 75, clinicians are left applying evidence derived from younger populations to older patients whose physiology, pharmacology, and risk profiles differ substantially. This evidence gap perpetuates both the undertreatment of conditions that could be managed effectively and the inappropriate use of interventions whose effects in older populations remain inadequately studied.
IAGG research also illuminates how stereotyping distorts clinical judgment in ways that are difficult to detect in real time. Older patients are significantly more likely to have their symptoms attributed to the aging process rather than investigated as distinct, treatable conditions. A 70-year-old presenting with persistent fatigue may be counseled to accept it as age-related, while a 45-year-old with the same complaint undergoes a comprehensive diagnostic workup. These patterns, individually subtle, accumulate over time into substantial disparities in diagnosis timing, treatment access, and long-term health outcomes.
IAGG’s Strategic Approach to Confronting Medical Ageism
The International Association of Gerontology and Geriatrics confronts age-based discrimination through several interconnected pillars: global policy advocacy, scientific research, professional education, and structured collaboration with international health institutions. Each pillar reinforces the others, forming a comprehensive framework for systemic change rather than isolated intervention.
Global Advocacy and Policy Engagement
IAGG holds consultative status at the United Nations and maintains active partnerships with the World Health Organization — affiliations that place the organization in a position to influence health policy at the highest global levels. IAGG has aligned with WHO’s Global Campaign to Combat Ageism and actively supports the UN Decade of Healthy Ageing (2021–2030), a framework that explicitly identifies ageism as a structural root cause of poor health in older populations worldwide.
Through formal position papers, participation in global health summits, and direct submissions to international policy bodies, IAGG advocates for healthcare frameworks that evaluate older patients on clinical merit rather than age-based assumptions. The organization has called consistently for the elimination of arbitrary age cutoffs from clinical trial inclusion criteria and for the protection of older adults within emergency triage protocols on the same evidentiary basis applied to all other patient groups.
Promoting Comprehensive Geriatric Assessment
One of IAGG’s most consistent clinical recommendations is the widespread adoption of Comprehensive Geriatric Assessment (CGA) as a structured and evidence-based counterweight to age-based assumptions. CGA is a multidimensional evaluation process that assesses a patient’s medical conditions, functional capabilities, cognitive status, nutritional health, and social circumstances in an integrated way.
Rather than using chronological age as a proxy for prognosis, CGA enables clinicians to build an accurate, individualized picture of a specific patient’s likely response to treatment. When applied before major oncological, cardiac, or surgical interventions, CGA has been shown to improve outcomes and ensure that older patients receive treatments they might otherwise have been denied based on age alone. The International Association of Gerontology and Geriatrics has championed the global expansion of CGA as a practical, implementable tool for reducing medical ageism in everyday clinical settings.
Education and Training in Geriatric Medicine
A substantial component of IAGG’s work targets medical education directly. If clinicians are never trained to recognize ageist assumptions within their own reasoning, those assumptions will continue to silently shape clinical decisions. IAGG supports the integration of gerontological principles — including explicit instruction on identifying and countering ageism — into medical school, nursing, and allied health curricula worldwide.
The organization’s World Congress of Gerontology and Geriatrics, convened every four years, functions as a major global platform for sharing research and best practices in age-equitable healthcare delivery. Symposia regularly examine the ethics of age-based resource allocation, the current evidence base for geriatric care, and healthcare system models that demonstrate how older adults can be served equitably and effectively.
Core Principles IAGG Advocates for Age-Equitable Medical Treatment
IAGG’s advocacy on age-based discrimination in medical care is built on a coherent set of principles that appear consistently across the organization’s scientific publications and policy communications. The table below outlines these core positions alongside their direct implications for clinical practice.
| Principle | Clinical Implication |
|---|---|
| Individualized assessment over age-based generalizations | Clinical decisions should reflect the patient’s functional status, comorbidities, and personal goals — not their birth year. |
| Inclusion of older adults in clinical research | Treatment evidence must be generated from populations that genuinely include older patients to be applicable and safe for them. |
| Comprehensive Geriatric Assessment before major interventions | Older adults facing surgery, chemotherapy, or complex procedures benefit from structured, multidimensional evaluation prior to treatment decisions. |
| Equitable access to pain and palliative care | Age should not determine a patient’s eligibility for, or quality of, pain management or comfort-centered care. |
| Transparency in age-related clinical reasoning | When age factors into a clinical decision, the reasoning must be individualized, evidence-based, and clearly documented in the patient record. |
| Professional accountability and continuing education | Healthcare providers should receive ongoing training to identify and correct ageist biases in their own clinical practice and institutional environments. |
These principles, advanced through IAGG’s scientific and policy channels over many years, provide a practical and adaptable framework for healthcare institutions seeking alignment with internationally recognized standards of geriatric care ethics.
The Real-World Consequences of Unaddressed Medical Ageism
When age-based discrimination goes unaddressed in healthcare systems, the consequences are both measurable and severe. Older adults who are denied appropriate cancer screening are more likely to present with late-stage disease, dramatically narrowing their treatment options and reducing survival chances. Those excluded from effective cardiac interventions face elevated rates of preventable mortality. Patients whose depression goes unrecognized and untreated suffer significant reductions in quality of life — and generate substantially greater downstream costs to healthcare systems through secondary complications.
IAGG research highlights that medical ageism does not affect physical health outcomes alone. It also systematically erodes the trust that older adults place in healthcare institutions. When patients repeatedly encounter clinical dismissiveness, feel that their concerns are minimized because of their age, or are denied referrals without explanation, many disengage from care altogether. They skip follow-up appointments, decline recommended screenings, and delay emergency visits until their conditions are critical and far more costly to manage.
The economic argument aligns closely with the ethical one. Healthcare systems that rely on age as a disqualifying criterion — rather than investing in appropriate, timely, individualized care — typically incur greater costs through delayed diagnoses, preventable hospitalizations, and management of conditions that could have been addressed earlier and less expensively. According to IAGG, confronting medical ageism is not merely a matter of ethical obligation; it is also a question of healthcare system efficiency and long-term sustainability.
What Age-Equitable Medical Care Looks Like in Practice
IAGG’s vision for age-equitable healthcare is not abstract idealism — it is grounded in specific, implementable changes to clinical protocols, institutional policies, and professional culture. Drawing from the organization’s published positions and affiliated research, the following reforms can meaningfully and measurably reduce age-based discrimination in medical settings.
- Revising clinical trial inclusion criteria to remove arbitrary age caps and establish the enrollment of older adults as a standard, enforceable scientific requirement.
- Embedding Comprehensive Geriatric Assessment into pre-treatment protocols for patients above a defined age or frailty threshold, particularly before major surgery or systemic cancer therapy.
- Developing and deploying institutional ageism audit tools that allow hospitals, clinics, and health systems to evaluate their own practices for age-discriminatory patterns in referrals, diagnoses, and treatment decisions.
- Standardizing age-neutral language within clinical guidelines, staff training materials, and institutional policies to reduce implicit bias at its source.
- Establishing dedicated geriatric consultation services within emergency departments, oncology units, and intensive care settings where ageist assumptions most frequently affect high-stakes decisions.
- Creating clear accountability mechanisms for documenting when age influences a treatment decision and whether that influence is grounded in individualized, evidence-based clinical reasoning.
Together, these measures form a coherent, actionable roadmap — one that directly reflects the principles IAGG has advanced for decades and that is increasingly recognized by health ministries, accreditation bodies, and medical associations around the world as a standard of responsible geriatric care delivery.
Conclusion
Age-based discrimination in medical treatment is a systemic problem that demands both intellectual honesty and institutional will to address. The International Association of Gerontology and Geriatrics (IAGG) has been a principled, evidence-driven voice in this effort for decades — precisely defining the problem, documenting its consequences through rigorous scientific research, and advocating for the structural changes that protect older adults’ fundamental right to equitable, individualized care.
The work of IAGG does not simply call for greater kindness toward older patients — though compassion remains central to good medicine. It calls for a fundamental reorientation of clinical decision-making: one in which age informs but never dictates, in which older adults are included rather than excluded from the research evidence base, and in which every patient — regardless of birth year — is evaluated on the full complexity of their individual clinical profile and personal circumstances.
For healthcare systems, clinicians, and policymakers committed to the highest global standards of geriatric care, the frameworks, research, and advocacy positions advanced by the International Association of Gerontology and Geriatrics represent both a moral compass and a practical guide for building medical environments where age is never a barrier to receiving the care a patient genuinely needs.